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Abstract
For over a century microbiologists and immunologist have categorized microorganisms as pathogenic or non-pathogenic
species or genera. This definition, clearly relevant at the strain and species level for most bacteria, where differences in
virulence between strains of a particular species are well known, has never been probed at the strain level in fungal species.
Here, we tested the immune reactivity and the pathogenic potential of a collection of strains from Aspergillus spp, a fungus
that is generally considered pathogenic in immuno-compromised hosts. Our results show a wide strain-dependent variation
of the immune response elicited indicating that different isolates possess diverse virulence and infectivity. Thus, the
definition of markers of inflammation or pathogenicity cannot be generalized. The profound understanding of the
molecular mechanisms subtending the different immune responses will result solely from the comparative study of strains
with extremely diverse properties.
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Introduction
The importance of fungal cell wall in prompting immune
response has been widely investigated indicating that a multilay-
ered cell wall controls the exposure of pathogen-associated
molecular patterns to immune cells [1,2]. So far, studies on
immune responses to fungi have for the vast majority used purified
antigens and eventually entire cells of reference pathogens
[1,2,3,4,5,6,7,8,9,10]. Often the use of different strains led to
different conclusions on the role of fundamental mechanisms, such
as those mediated by different receptors [11,12,13,14,15].
Recently, the use of in vitro primary cell culture systems has been
proposed as a viable strategy for a first screening of mutant strains
of Candida spp., to identify virulence traits with regard to host cell
response and pathogen invasion [16].
The definition of pathogenic fungal species is also a concept
whose borders have yet to be properly delineated. Fungi have
developed a variety of mechanisms for evading or down-regulating
the host immune response, mainly by modification of cell wall
component exposure. Phenotypic switching is a strategy employed
by several pathogenic fungi such as Candida albicans, being able to
switch from a non-pathogenic cell-round shape, the yeast form, to
the pathogenic hyphal form. Similarly, Aspergillus fumigatus
encounters the immune system in a variety of developmental
stages from conidia through to mature mycelium. Hyphal
formation is associated with loss of proper recognition and a shift
towards anti-inflammatory response or evasion mechanisms [17].
A. fumigatus is currently the major air-borne fungal pathogen and is
generally regarded as a passive opportunistic pathogen. Produc-
tion of scavenger molecules, such as melanin, mannitol, catalase
and superoxido-dismutase, enables Aspergillus spp. to resist damage
by reactive oxygen intermediates [18,19,20]. Thus, according to
current knowledge, even the most aggressive pathogen, such as A.
fumigatus, lacks virulence traits of the sophistication shown by those
evolved in bacteria. Its ability to establish infection seems mainly
due to its robustness and ability to adapt to a wide range of
environmental conditions [20].
Although the anti-inflammatory potential of specific microbial
strains was occasionally suggested in vitro [21,22] or in animals
[22,23], few independent observations support the idea that fungal
strain variability could explain differences in immune response
[23,24]. Additionally, our existing knowledge of immune response
to A. fumigatus is derived from a wide range of isolates. To our
knowledge, no studies have systematically addressed fungal
immune reactivity at the strain level.
To investigate how the origin, ecological niches and phenotypic
properties could affect the host immune reactivity to A. fumigatus,
we screened a diverse set of strains for their pathogenic and
immuno-modulatory performance. Selected candidate strains were
then tested on animal models. This study offers new clues whether
the commonly studied molecular components of these pathogens
are really sufficient to account for the immune response to the live
pathogen. Determining whether strain specific differences in the
immune responses are either advantageous to the pathogen, or to
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the host, improves our understanding of host-pathogen interac-
tions and suggests a need to rethink our understanding of the
pathogenicity concept in fungi.
Materials and Methods
Ethics Statement
For the in vitro experiments using human cells, the experimental
plan was approved by the local Ethical Committee of Azienda
Universitaria Ospedaliera Careggi (AUOC, Careggi Hospital,
Florence; Italy), and written informed consent was obtained from
all donors (approval document n. 87/10). The study was designed
in conformity with the international recommendation (Dir. EU
2001/20/EC) and its italian counterpart (DM 15 Luglio 1997;
D.Lvo 211/2003; D.L.vo 200/2007) for clinical trial and following
the Declaration of Helsinki, to assure protection and care of
subjects involved. In mouse models, experiments were performed
according to the Italian Approved Animal Welfare Assurance A-
3143-01 and Legislative decree 157/2008-B regarding the animal
licence obtained by the Italian Ministry of Health lasting for three
years (2008–2011). Infections were performed under avertin
anesthesia and all efforts were made to minimize suffering. As
clearly described by Clemons and Stevens [25], the outcome of
pulmonary aspergillosis critically depend on the inocula, such as
too severe an infection result in early deaths, presumably
associated with an acute inflammatory response, whereas an
inoculum that is too low may result in no mortality and even
clearance of the fungus. Therefore, there are no solid evidence to
establish the correspondence of early clinical signs and final disease
outcome in murine aspergillosis and alternative, surrogate end-
points are lacking. The experimental protocol was designed in
conformity with the recommendations of the European Economic
Community (86/609/CEE) for the care and the use of laboratory
animals, was in agreement with the Good Laboratory Practices
and was approved by the animal care Committee of the University
of Perugia (Perugia, Italy).
Fungal Strains
A. fumigatus strains used in the study are listed in Table 1. To
obtain color mutants, spores from a single colony of Af293 were
collected and subjected to UV mutagenesis. 20 ml of each spore
suspension (107 viable spores ml21) was gently agitated by a
magnetic flea in a glass petri dish (with the lid removed) 4 cm
below a UV lamp (UVP, model: R-52G). A dose response
experiment was carried out by removing 0.5 ml samples at 20 s
intervals over a 100 s period. Irradiated spore suspensions were
stored in foil-wrapped Eppendorf tubes at 4uC overnight to avoid
photoreactivation. Dilutions of spore suspension were made in
sterile distilled water in foil-wrapped Eppendorf tubes. Samples of
spore suspension, which had been exposed to up to 60 seconds of
UV irradiation, were diluted in sterile distilled water by factors of
103 and 104. 0.1 ml aliquots of these dilutions were spread onto
Vogel’s agar plates (3 replicates per dilution) using a flame-
sterilised glass spreader. Samples taken after 60 s were diluted by
factors 101, 102 and 103. All plates were incubated in the dark at
37uC. Colonies were counted initially after two days and finally
after four days of incubation. A kill curve was plotted to estimate
the exposure time to UV light to kill 95% of spores. This was then
used for subsequent mutagenesis procedures and UV irradiated
spores were kept at 4uC in a foil-wrapped universal tube. The
mutagenized spores were spread onto SAB medium at a
concentration to give 50–70 colonies per plate and incubated at
37uC for 2–3 days. Triton X-100 (0.1%) was included in the
medium to restrict colony growth. The colour mutants were
selected by visual inspection. For the melanin pathway mutants,
gene knockout cassettes were constructed by modified PCR fusion
method using primers shown in Table S1 [26] Primers hph_F and
hph_R, which contained the PCR fusion linkers
‘‘CCGGCTCGGTAACAGAACTA’’ and ‘‘GGGAGCA-
TATCGTTCAGAGC’’, were used to amplify the hygromycin
selectable marker, a ,2.8 kb hygromycin B phosphotransferase
cassette from pAN7-1 under the gpdA promoter and TtrpC
terminator. The hygromycin cassette was fused to upstream and
downstream flanks of alb1, arp1, arp2, ayg1, abr2 and rodA to make
the final knockout cassette as previously described [27]. Gene
knockout cassettes were used to delete transporter genes in the
CEA10 derived strain A1160 DKu802 pyrG+. Fungal transforma-
tions were performed using previously described methodologies
[27]. Transformants were selected on YPS media (2% yeast
extract, 0.5% peptone, 0.9 M sucrose, 5 mM Tris, 1.5% technical
agar, pH 6.0) supplemented with 200 mg/ml hygromycin B
(Melford) and incubated at 37uC until the appearance of resistant
colonies. Growing colonies were streaked on SAB agar supple-
mented with 200 mg/ml hygromycin B and a single colony from
each strain was grown on the same media for DNA extraction and
other subsequent analyses. Transformed colonies were screened by
PCR using the flanking primers from the first step of the PCR
fusion reaction (P1 and P4), which appear outside the boundary of
the gene KO cassette. Primer set P1 and hph_R was used to
confirm the insertion of the upstream flank whilst set hph_F and
P4 was used to confirm insertion of the downstream flank.
Additionally primers P9 and P10, which match the sequence of the
target gene, were used to confirm gene deletion. A. fumigatus
clinical isolates were obtained from the Mycology Reference
Centre Manchester (MRCM). All mutants in the uridine
biosynthetic pathway were isolated by selection on fluoro-orotic
acid (5-FOA). PyrG mutation was confirmed by transforming
isolates with the AfpyrG gene. Mutants in the nitrate assimilation
pathway were isolated by selection on 600 mM potasium chlorate.
NiaD mutants were confirmed by their ability to grow in the
presence of hypoxantheine and nitrite as sole nitrogen sources but
not nitrate. A complete list of the primers used for the generation
of Aspergillus mutants is reported as Table S1.
Human Cell Preparation and Stimulation
PBMCs were isolated from buffy coat blood sample from 6
healthy donors from the Transfusion Unit of the Careggi Hospital
(Florence, Italy) by Ficoll-Hypaque density gradient centrifugation
(Biochrom AG). For DC experiments, monocytes were isolated
from low density PBMCs by magnetic enrichment with anti-CD14
beads (Miltenyi Biotec). Cells were cultured in the presence of
GM-CSF (800 U/ml) and recombinant IL-4 (1000 U/ml) for 6
days to allow DC differentiation [28]. DC activation was induced
by fungal strains in the different life stages. Depending on the
experiments, moDCs were added at different concentrations. A
serial dilution of live/UV-treated yeast preparations was added to
the moDCs at different stimuli:DC ratios. For confirmation
experiments, PBMCs from the same healthy subjects were used;
stimulation was performed as in DC challenge experiments. For
RT-PCR cells were collected after 24 hr or 5 days of stimulation.
Supernatants were collected after 5 days of stimulation for
cytokine detection.
Fungal Infections and Treatments
For in vitro experiments, A. fumigatus hyphae or conidial
preparation were performed as previously described [14]. It
should be noted that in some of the experiments performed in this
study, UV-killed microorganisms were used otherwise properly
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indicated. UV-treatment was performed on recovered cultures for
2 h. A viability assay was conducted by CFU counting after
plating the cultures on agar plate post-treatment. For infection,
female C57BL6 mice, 8–10 wk old, were purchased from Charles
River (Calco, Italy). Mice were anesthetized by intraperitoneal
(i.p.) injection of 2.5% avertin (Sigma Chemical Co, St. Louis,
MO) before instillation of a suspension of 26107 viable conidia/
20 ml saline intranasally (i.n.). Fungi were suspended in endotoxin–
free (Detoxi–gel; Pierce, Rockford, IL) solutions (,1.0 EU/mL, as
determined by the LAL method). Mice were monitored for fungal
growth in lung and brain (CFU/organ, mean 6 SE), survival
(MST, days), histopathology (Periodic acid–Schiff (PAS)-staining
of sections of paraffin–embedded tissues) and patterns of cytokine/
chemokine gene expression and production. No other clinical signs
could be recorded, despite the fact that the brain infection with
Aspergillus is the most common extra-pulmonary site of infection,
and one that results in about 80% mortality [25]. Bronchoalveolar
lavage (BAL) was performed by cannulating the trachea and
washing the airways with 3 ml of PBS to collect the BAL fluid.
Total and differential cell counts were done by staining BAL
smears with May–Gru¨nwald Giemsa reagents (Sigma) before
analysis. At least 200 cells per cytospin preparation were counted
and the absolute number of each cell type was calculated.
Photographs were taken using a high–resolution Microscopy
Olympus DP71 (Olympus, Milan, Italy).
Cytokine Production
At the indicated times, supernatants from human cell cultures
were collected and cytokine detection was performed using the
MilliplexH MAP human cytokine/chemokine kit (Millipore),
according to the manufacturer’s instructions. Cytokine levels on
lung homogenates from infected mice were determined a week
after the infection by enzyme-linked immunosorbent assays (BD
Biosciences Pharmingen, R&D Systems and eBioscience). The
detection limits (pg ml) of the assays were ,10 for IFN-c, ,3 for
IL-10, ,10 for IL-17A.
Real–time PCR
Human total RNA was extracted with the Rneasy Mini Kit
(Qiagen, Milan, Italy) from human PBMCs derived from 6 distinct
donors. Random hexamers and reverse transcriptase kit (Super-
Script II, Invitrogen) were used for cDNA synthesis. Transcripts
for IL-6, IL-10, TNA, IL1B, IL-17A, and IFNG genes were
quantified with Applied Biosystems predesigned TaqMan Gene
Expression Assays and reagents according to the manufacturer’s
instructions. Quantification of the PCR signals was performed by
comparing the cycle threshold (Ct) value of the gene of interest
with the Ct value of the reference gene GAPDH. Values are
expressed as fold increase of mRNA relative to that in
unstimulated cells. Murine total RNA was extracted from lungs
using RNeasy Mini Kit and was reverse transcribed with
Sensiscript Reverse Transcriptase (Qiagen) according to the
manufacturer’s directions. The sense/antisense primers were as
described [29]. Real–time RT–PCR was performed using the
iCycler iQ detection system (Bio–Rad) and SYBR Green
chemistry (Finnzymes Oy, Espoo, Finland). Quantification of the
PCR signals was performed by comparing the cycle threshold (Ct)
value of the gene of interest with the Ct value of the reference gene
GAPDH. Values are expressed as fold increase of mRNA relative
to that in unstimulated cells.
Statistics
For the DC experiments, statistically significance was evaluated
using a Mann-Whitney test and a post-hoc comparison. Results,
expressed as p-value, are reported for each cytokine measurement
and for each strain comparison in Table S2. For human PBMCs
and mice data, a paired t-test comparison was used.
Results
Immune-based Diversity of Different Common
Laboratory Aspergillus Strains
Several strains of A. fumigatus originally isolated from a clinical
setting are in regular use as laboratory strains, these include the
sequenced strain Af293, CEA10 and Af300 (Table 1).
The cytokine induction pattern for these 3 laboratory strains
along with an A. nidulans ‘laboratory’ isolate was evaluated by an
in vitro assay challenging monocyte derived DCs from 6 distinct
healthy donors with either hyphae or fungal conidia. Pattern
recognition receptors expressed on these immune cells contribute
to the specific detection of fungi [30,31]. Direct contact with fungi
leads to the maturation of DCs, which is characterized by an
increase in antigen presentation, expression of costimulatory
Table 1. Complete list of the strains used in the study.
Name Species Origin References
A4 A. nidulans Manchester Nierman et al., 2005 [44]
Af293 A. fumigatus Manchester Nierman et al., 2005 [44]
Af293 pyrG2 A. fumigatus Manchester this work
Af293 VKBR1 A. fumigatus Manchester this work
Af293 VKBR2 A. fumigatus Manchester this work
Af293 VKBR3 A. fumigatus Manchester this work
Af293 VKBR4 A. fumigatus Manchester this work
Af293 VKBR5 A. fumigatus Manchester this work
Af293 VKOL1 A. fumigatus Manchester this work
Af293 VKWH1 A. fumigatus Manchester this work
Af293 VKWH2 A. fumigatus Manchester this work
Af293 VKLG1 A. fumigatus Manchester this work
Af300 A. fumigatus Manchester this work
Af300 niaD2 A. fumigatus Manchester this work
CEA10 (CBS144-89 ) A. fumigatus Paris Beauvais et al., 1997 [45]
CEA10 pyrG2 A. fumigatus Manchester this work
CEA10 pyrG2 niaD2 A. fumigatus Manchester this work
alb1 A. fumigatus Manchester this work
roda A. fumigatus Manchester this work
abr2 A. fumigatus Manchester this work
ayg1 A. fumigatus Manchester this work
arp1 A. fumigatus Manchester this work
arp2 A. fumigatus Manchester this work
F14206 A. fumigatus Manchester this work
F15767 A. fumigatus Manchester this work
F12760 A. fumigatus Manchester this work
F16216 A. fumigatus Manchester this work
F11678 A. fumigatus Manchester this work
F12041 A. fumigatus Manchester this work
F12285 A. fumigatus Manchester this work
F11628 A. fumigatus Manchester this work
F13402 A. fumigatus Manchester this work
doi:10.1371/journal.pone.0056651.t001
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molecules and cytokine production. In our assays, tumor necrosis
factor alpha (TNF-a) and interleukin (IL)-10, IL-1ß, IL-6, IL-
12p70 and IL-23 levels were measured (Figure 1A). This
investigation indicate that a large diversity in the immuno-
modulatory profiles exists among A. fumigatus strains as quantified
directly by cytokine comparison, rather than the traditional IL-10/
IL-12 ratio [32,33], which obviously is inappropriate here to
describe the high complexity of the fungal morphotype-dependent
immune response [33]. Statistical analysis indicated that the strain-
dependent cytokine variation was significantly different among the
strains tested (Figure 1A and Table S2). Release of pro-
inflammatory mediators, such as TNF-a was very high; by
contrast, a weak induction of IL-12p70 was observable irrespective
of the developmental stage of the fungus (Figure 1A). In addition to
the high donor variability observed, the screening revealed a
highly strain-dependent induction of IL-10 and IL-1 ß. A. nidulans
A4 and A. fumigatus Af293 strain elicited a high induction of IL-10
and IL-1ß while A. fumigatus Af300 and CEA10 were less potent
inducers of these cytokines. We extended our examination of the
strains to include the response of PBMCs to live fungal cells.
Consistently with the previous results Af300 and CEA10 elicited a
higher inflammatory response whereas Af293 and A4 did not
(Figure 1B–C). To correlate the cytokine profiles with the ability of
these strains to prime for TH1 or TH17 adaptive immune
responses, human PBMCs were stimulated with live strains and
both gene transcripts for IFNG and IL17A and their cytokine levels
were evaluated on stimulated PBMCs (Figure 1B–C). The WT
Af293 and A4 strains induced more INF-c and less IL-17A hence
suggesting initiation of a TH1 response; by contrast the WT Af300
and CEA10 strains induced more IL-17A. We will indicate them
as ‘‘inflammatory’’ (Af293 and A4) and ‘‘hyper-inflammatory’’
(Af300 and CEA10) along the text.
The Different WT Strains Induce Disparate Inflammatory
Responses in Mice
The majority of virulence studies that assessed the pathogenicity
of Aspergillus strains have been performed in immunosuppressed
models. We assessed the pathogenic potential of the different
fungal strains in vivo in immunocompetent C57BL/6 mice, whose
immunological response to the fungus is well characterized
[34,35]. Mice were intranasally inoculated with the different
fungal strains and parameters of infection were evaluated in terms
of survival, fungal growth in the lung and dissemination into the
brain, histopathology and cytokine/chemokine gene expression
and production. As reported in Figure 2, important differences
were observed among the different WT strains (two ‘‘hyper-
inflammatory’’, i.e, AF300 and CEA10 and two ‘‘inflammatory’’,
i.e., A. nidulans and Af293). All mice, except those infected with
CEA10, survived the infection. The fungal growth in the lung and
brain was apparently higher, early in infection, in mice infected
with the ‘‘hyper-inflammatory’’ as compared to the inflammatory
strains; however, clearance of the fungus was higher in mice
infected with the ‘‘hyper-inflammatory’’ as compared to the
other2 strains. The higher fungal burden and increased fungal
clearance was associated with a noticeable inflammatory pathol-
ogy in the lung of mice infected with the ‘‘hyper-inflammatory’’
strains, as revealed by increased infiltration of inflammatory cells,
particularly neutrophils, and the increased expression of Cxcl1 and
Cxcl2 chemokines. Of interest, the levels of inflammatory/anti-
inflammatory cytokines strictly mirrored those observed in vitro, as
the production of IL-1ß and IL-17A were locally higher in mice
infected with the ‘‘hyper-inflammatory’’ strains. Neither IFN-c nor
IL-10 was instead elevated in mice infected with the Af300 and
CEA10 strains. These data indicate that different inflammatory
responses, likely affecting the outcome of the infection, are elicited
by different Aspergillus WT strains in vivo.
Effects of Mutation Introduction on the Immune
Response Elicited by Different WT Strains
To examine the effects of attenuation of virulence on the murine
response we used isolates deficient in UMP biosynthetic pathway
in the CEA10 genetic background. Introducing pyrG2 and pyrG
niaD2 mutations causes auxotrophy for uridine and uracil and as a
result, mutant strains are unable to establish an infection in a
murine host [36]. We found that in our genetic backgrounds, UV-
killed spores of both mutants induce a similar-or even stronger-
inflammatory response in vitro compared to that prompted by the
respective WT counterpart (Figure 3A). When live cells were used
to challenge PBMCs, CEA10 pyrG2niaD2, which is unable to
germinate, induced high levels of production of IL-10 and INF-c
and low levels of IL-17A modulating the TH17 response of the
wild-type isolate to a TH1 response. (Figure 3B–C). Interestingly,
the levels of inflammatory cytokines were higher after DC
stimulation with the Af300 niaD strain as compared to the WT
strain, as also indicated by the high level of IL-17A (Figure 3B–C).
In vivo experiments confirmed the in vitro results. Assessment of
virulence of the CEA10 pyrG niaD2 strain in the murine model
confirmed it was unable to cause mortality (Figure 3D). The fungal
growth and the host inflammatory response were indeed reduced,
as revealed by histopathology of the lung and expression of
inflammatory cytokines and chemokines as compared to mice
infected with the virulent CEA10 WT strain (Figure 3D).
Interestingly, the virulence of a niaD2 mutant in a different
genetic background, such as Af300 strain, was instead increased, as
revealed by the in vitro inflammatory response (Figure 4A–C) as
well as the decreased survival, unrestrained fungal growth and
high levels of inflammatory cytokine production in vivo (Figure 4D).
However, in this context, it is unlikley that the nitrate reductase
gene (niaD) is responsible for this change in phenotype. The
mutation of the niaD gene in this strain is as a result of a
chromosomal translocation and as such other mutations are
present in this strain. It is unlikley that loss of nitrate reductase
would lead to an increase in virulence, therefore another as yet
undefined mutation in the strain is probably contributing to this
phenotype. Nevertheless, such result indicates once more how
mutations/translocations normally occurring in nature could
profoundly affect virulence and immuno-modulatory properties.
Melanization, Cytokine Release and Virulence
Melanization in A. fumigatus confers bluish-grey color to conidia.
Previous studies have observed an association with the melaniza-
tion of the conidial cell wall, the ability to elicit an immunological
response from human PBMCs, and increase in strain pathogenic-
ity [18]. To further investigate how the phenotypic properties
could affect the host immune reactivity to A. fumigatus, we screened
a set of color mutants for their immuno-modulatory performance.
In particular, 9 A. fumigatus Af293 color mutant strains were
obtained by UV mutagenesis as described in Material and
Methods and selected for their different colony colors (WH,
white; BR, brown). After DC stimulation, all the mutants induce a
similar -or even stronger- inflammatory response to that prompted
by their respective WT counterpart as indicated by the different
pattern released by either the conidial or the hyphal form of the
strains (Figure 5A). Af293 conidia elicit a strong IL-10 production,
while its color mutant strains revealed a trend to lower induction of
IL-10. In particular, while some strains induce high level of IL-10
(Af293 VKWH2, VKBR1, VKBR3 and VKBR4) others do not
(VKBR2, VKBR5, VKWH1 and VKOL1). A significant reduc-
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Figure 1. Immune response to different WT Aspergillus strains. Different WT strains elicit diverse inflammatory responses and prime peculiar
adaptive Th response. (A) DCs were cultured with UV-killed conidia or hyphae of WT strains for 24 hours or without any stimuli (unstimulated, us) and
supernatants were used for TNFa, IL-10, IL-1b, IL-6, IL-12p70 and IL-23 measurements. Data are represented as mean+SD (N= 6), *p#0.05, **p#0.01,
INF2 conidia vs INF+conidia; 1p#0.05, 11p#0.01, INF2 hyphae vs INF+ hyphae. Complete statistically significant p-values are collected in Table S2. (B,C)
Healthy PBMCs were cultured with live conidia or without any stimulus, and cytokine protein (A) and transcript (B) levels were measured. Data are
represented as mean+SD (N= 6), *p#0.05, **p#0.01, INF2 vs INF+ strains.
doi:10.1371/journal.pone.0056651.g001
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tion in IFN-c production and a concordant increase of IL-17A
level was observed when PBMCs were challenged with live conidia
from the 5 strains exhibiting a pro-inflammatory response from
DCs (Figure 5B and 5C). The murine infection model further
confirmed the inflammatory changes induced by the spore colour
mutants as compared to the WT strain, as indicated by the
elevated fungal burden and fungal persistence, dissemination into
the brain and pattern of tissue inflammation and inflammatory
response (Figure 6). Quite unexpectedly, among the strains
inducing the worsen outcome, we identified the Af293 VKWH1
and Af293 VKWH2 strains, characterized, respectively, by a
sandy and an albino conidial phenotypes.
The increase in inflammation caused by spore colour mutants
derived from a strain deemed to be anti-inflammatory led us to
investigate the role of pigmentation in a strain already thought to
be pro-inflammatory (CEA10). We generated gene knockouts in
the A. fumigatus melanin biosynthetic cluster genes (alb1, arp2, arp1,
abr2 and ayg1) [29,30,31,32,33] and used live conidia to challenge
Figure 2. In vivo immune reactivity to A. fumigatusWT strains. C57BL/6 mice were infected intranasally with different strains of A. fumigatus (6
mice/group). Survival (%), fungal growth (mean log10 CFU 6 SE, N= 3) in the lungs and brains of infected mice were assessed at different days post-
infection (dpi). The CFUs between wild-type and the corresponding mutant strains were statistically significant (p values ranging from #0.01 to
#0.001). Lung histology (PAS staining) and BAL morphometry [%, mean 6 SD, of mononuclear (MNC) or polymorphonuclear (PMN) cells] were done
at 4 dpi. Representative images of two independent experiments were depicted; bars indicate magnifications. Total lung RNA was extracted at 4 dpi
and the relative expression of Il1b, Cxcl1 and Cxcl2 genes was assessed by RT-PCR. Lung homogenates at 4 dpi were tested for levels of IL-17A, IFN-c,
and IL-10 by specific ELISA (mean values 6 SD, N= 3). *p#0.05, **p#0.01 and ***p#0.001, wild-type strains vs uninfected mice.
doi:10.1371/journal.pone.0056651.g002
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human DCs. In parallel we assessed the DC cytokine responses to
a strain deficient in the rodlet/hydrophobin layer (rodA knock out
mutant) [37]. In general, we observed a reduction in the
inflammatory cytokine response from the melanin mutants. All
of the knockouts showed a significant reduction in their capacity to
induce TNF-a whilst displaying an increase in their ability to
induce IL-12p70. RodA normally encapsulates dormant spores, its
removal results in the exposure of underlying proteins on the spore
surface. It has been demonstrated that dormant conidia of a rodA
mutant induces high levels of the pro-inflammatory cytokine TNF-
Figure 3. Immune response to different Aspergillus mutant strains. Different mutant strains elicit diverse inflammatory responses and prime
peculiar adaptive TH response. (A) DCs were cultured with UV-killed conidia or hyphae for 24 hours or without any stimuli (unstimulated, us) and
supernatants were used for TNFa, IL-10, IL-1b, IL-6, IL-12p70 and IL-23 measurements. Data are represented as mean+SD (N= 6), *p#0.05, **p#0.01,
conidial mutant strains vs the conidial WT strain; 1p#0.05, 11p#0.01, hyphal mutant strains vs hyphal WT strain. Complete statistically significant p-
values are collected in Table S2. (B,C) Healthy PBMCs were cultured with live conidia or without any stimulus, and cytokine protein and transcript
levels were measured. Data are represented as mean+SD (N= 6), *p#0.05, **p#0.01, mutants strain vs WT strain. (D) C57BL/6 mice were infected
intranasally with different strains of A. fumigatus (6 mice/group). Survival (%), fungal growth (mean log10 CFU 6 SE, N= 3) in the lungs and brains of
infected mice were assessed at different days post-infection (dpi). The CFUs between wild-type and the corresponding mutant strains were
statistically significant (p-values ranging from #0.01 to #0.001). Lung histology (PAS staining) and BAL morphometry [%, mean 6 SD, of
mononuclear (MNC) or polymorphonuclear (PMN) cells] were done at 4 dpi. Representative images of two independent experiments were depicted;
bars indicate magnifications. Total lung RNA was extracted at 4 dpi and the relative expression of Il1b, Cxcl1 and Cxcl2 genes was assessed by RT-PCR.
Lung homogenates at 4 dpi were tested for levels of IL-17A, IFN-c, and IL-10 by specific ELISA (mean values 6 SD, N= 3). *p#0.05, **p#0.01 and
***p#0.001, wild-type strains vs uninfected mice or mutants strains vs the wild-type strain.
doi:10.1371/journal.pone.0056651.g003
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a and IL-12p70 from human DCs when compared to the wild-
type isolate (Aimanianda et al 2009). Our results show this is
apparent even when a live rodAD mutant is used as a challenge to
DCs suggesting that the rodlet layer has a role in shielding proteins
in hyphae as well as conidia (Figure 7). In contrast to Aimanianda
et al, but in keeping with a pro-inflammatory response, we
observed a reduction in the production of IL-10. Since in nature,
a great variety of colored strains exists, we compared the cytokine
response to the mutant strains to the one induced by 9 A. fumigatus
isolates from patients with chronic aspergillosis in an attempt to see
Figure 4. In vivo immune response to A. fumigatus mutant strains. Different mutant strains elicit diverse inflammatory responses and prime
peculiar adaptive TH response. (A) DCs were cultured with UV-killed conidia or hyphae for 24 hours or without any stimuli (unstimulated, us) and
supernatants were used for TNFa, IL-10, IL-1b, IL-6, IL-12p70 and IL-23 measurements. Data are represented as mean+SD (N= 6), *p#0.05, **p#0.01,
conidial mutant strains vs the conidial WT strain; 1p#0.05, 11p#0.01, hyphal mutant strains vs hyphal WT strain. Complete statistically significant p-
values are collected in Table S2. (B,C) Healthy PBMCs were cultured with live conidia or without any stimulus, and cytokine protein and transcript
levels were measured. Data are represented as mean+SD (N= 6), *p#0.05, **p#0.01, mutants strain vs WT strain. (D) C57BL/6 mice were infected
intranasally with different strains of A. fumigatus (6 mice/group). Survival (%), fungal growth (mean log10 CFU 6 SE, N= 3) in the lungs and brains of
infected mice were assessed at different days post-infection (dpi). The CFUs between wild-type and the corresponding mutant strains were
statistically significant (p values ranging from #0.01 to #0.001). Lung histology (PAS staining) and BAL morphometry [%, mean 6 SD, of
mononuclear (MNC) or polymorphonuclear (PMN) cells] were done at 4 dpi. Representative images of two independent experiments were depicted;
bars indicate magnifications. Total lung RNA was extracted at 4 dpi and the relative expression of Il1b, Cxcl1 and Cxcl2 genes was assessed by RT-PCR.
Lung homogenates at 4 dpi were tested for levels of IL-17A, IFN-c, and IL-10 by specific ELISA (mean values 6 SD, N= 3). *p#0.05, **#0.01 and
***p#0.001, wild-type strains vs uninfected mice or mutants strains vs the wild-type strain.
doi:10.1371/journal.pone.0056651.g004
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if any variability exists in the immune reactivity of the isolates
(Figure 7). The conidia from these strains exhibited a range of
spore colour phenotypes, varying from brown conidia (F15767,
F16215) to brownish-green conidia (F12041, F12285), from sand
colonies (F13402, F14206) to colonies sand-coloured at the edge
and green in the centre (F12760), to almost white conidia (F11628
and F11698), possibly indicating a different melanin content. We
saw an exceptionally wide variability in the cytokine response to
the clinical isolates. Despite several isolates show similarity with
the knockout mutants, we could not perfectly match the pro-
inflammatory phenotype of the isolates with the colour feature. As
an example, rodA strain and F15767 present similar color
phenotype (data not shown) and are both inflammatory as
indicated by the low IL-10 induction. By contrast, even if
F11628 strain presents white conidia as alb1 strain, it induces
lower level of IL-10 with respect to the albino strain. Thus, there
was no discernible pattern to the way in which the DCs responded
to the different strains except that all strains induced low levels of
the anti-inflammatory IL-10 and a higher production of pro-
inflammatory cytokines such as TNF-a, IL-1b and IL-12p70
(Figure 7). The overall results indicate that pigmentation is not a
clear indicator of the strain pathogenicity as it may contribute very
little in some strains but more in others.
Discussion
In the bacterial kingdom it is well recognised that certain
members of a species can vary in their ability to cause disease.
However fungi are less well studied and it is assumed that all
members of a species have equal ability to cause disease or induce
immune responses. As a consequence, there has been little effort to
standardise strains used for these studies in different laboratories.
Emerging fungal pathogens are unexpectedly becoming an
ever-increasing threat in the world, in particular in immune
compromised patients [38,39,40]. Because of the poor outcome of
current treatments of invasive fungal infection, it is imperative to
understand the nature of fungal pathogenesis and to develop more
effective therapies for combating invasive fungal infection in
humans. Given the importance to studying the nature of fungal
pathogenesis, it becomes necessary to explore immune-based
diversity of strains derived from different ecological niches. Several
studies worldwide have attempted to address pathogenicity
mechanisms using different strains as a model. It is known that
different isolates of A. fumigatus possess divergent genomes and
gene complements [41].
In this study we aimed at probing the DC immune response to
the opportunistic fungal species Aspergillus, allowing an in vitro
Figure 5. Immune response to different Aspergillus color mutants. Different mutant strains elicit diverse inflammatory responses and prime
peculiar adaptive TH response. (A) DCs were cultured with UV-killed conidia or hyphae for 24 hours or without any stimuli (unstimulated, us) and
supernatants were used for TNFa, IL-10, IL-1b, IL-6, IL-12p70 and IL-23 measurements. Data are represented as mean+SD (N= 6), *p#0.05, **p#0.01,
conidial mutant strains vs conidial WT strain; 1p#0.05, 11p#0.01, hyphal mutant strains vs hyphal WT strain. Complete statistically significant p-values
are collected in Table S2. (B,C) Healthy PBMCs were cultured with live conidia or without any stimulus, and cytokine protein and transcript levels were
measured. Data are represented as mean+SD (N= 6), *p#0.05, **p#0.01, mutants strain vs WT strain.
doi:10.1371/journal.pone.0056651.g005
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preliminary classification and characterization of different strains
according to their immune reactivity. To this end, we categorized
the strains based on the cytokine secretion profile of Aspergillus-
stimulated DCs. Confirmation experiments were performed using
PBMCs and the ability of particular strains to induce inflammation
were further tested in mice.
In addition to the high donor variability observed, the screening
revealed a strong strain-specific variation of the in vitro cytokine
induction profiles after stimulation of immuno-competent cells,
highlighted by the variable levels of IL-10 and IL-1b. For all the
strains tested, independently to their cell form (conidia or hyphae),
release of pro-inflammatory mediators, such as TNF-a, was very
high; by contrast a weak induction of IL-12p70 was observable
either upon conidial or hyphal stimulation. Statistical analysis
indicated that the strain-dependent cytokine variation was
significantly different among the strains tested (Table S2) and
differences between blood donors did not affect the comparison of
the strains based on their cytokine profiles as the patterns of DC
responses to various strains were consistent from one donor to
another. This investigation confirmed the large diversity in the
immuno-modulatory profiles among A. fumigatus strains.
Despite the fact that the in vitro assay does not clarify the
physiological mechanism(s) involved, it is well accepted as a proxy
of how the immune system may sense the fungal strains and
consequently polarise the immune response. Strains leading to a
high IL-10/IL-12 ratio would more easily slow down an early TH1
response, while a high IL-10/IL-23 ratio would counterbalance an
early TH17 response. In accordance to this hypothesis we found
differences in the in vivo inflammatory potential of the tested
strains. These differences were markedly observable upon DC
stimulation with WT strains, allowing us to categorize the strains
as ’’inflammatory’’ or ‘‘hyper-inflammatory’’. The observation
that diverse WT strains elicit opposite responses suggest that the
use of various WT strains could therefore compromise a correct
understanding of the recognition mechanisms, usually based on
the introduction of gene mutations. As such, the mutants derived
from the ‘‘hyper-inflammatory’’ CEA10 and Af300 WT strains
induce different immune responses either in vitro or in vivo. This
observation highlights how genetic adaptation of the fungus to the
host environment could influence its virulence and infectivity.
Understanding the determinants contributing to the different
responses of WT strains is the major follow up to this study, yet
requires a substantial investment in resources and is currently
under active investigation. The observation that the presence of a
mutation could lead to a complete opposite outcome stresses even
more the need to consider the strain specific variation traits.
Figure 6. In vivo immune response to A. fumigatus color mutants. C57BL/6 mice were infected intranasally with different strains of A. fumigatus
(6 mice/group). Survival (%), fungal growth (mean log10 CFU 6 SE, N= 3) in the lungs and brains of infected mice were assessed at different days
post-infection (dpi). The CFUs between wild-type and the corresponding mutant strains were statistically significant (p values ranging from #0.01 to
#0.001). Lung histology (PAS staining) and BAL morphometry [%, mean 6 SD, of mononuclear (MNC) or polymorphonuclear (PMN) cells] were done
at 4 dpi. Representative images of two independent experiments were depicted; bars indicate magnifications. Total lung RNA was extracted at 4 dpi
and the relative expression of Il1b, Cxcl1 and Cxcl2 genes was assessed by RT-PCR. Lung homogenates at 4 dpi were tested for levels of IL-17A, IFN-c,
and IL-10 by specific ELISA (mean values 6 SD, N= 3). *p#0.05, **p#0.01 and ***p#0.001, wild-type strains vs uninfected mice or mutants strains vs
the corresponding wild-type strain.
doi:10.1371/journal.pone.0056651.g006
Figure 7. Effect of melanin content in the immune reactivity of A. fumigatus clinical isolates. Ability of DC to discriminate among different
melanin color mutants and clinical isolates of the Aspergillus species was tested as differential cytokine production. DCs were cultured with live
conidia of wt CEA10 strain, different knock out (KO) mutants, Aspergillosis isolates or without any stimulus (unstimulated, us) for 24 hours and
supernatants used for TNFa, IL-10, IL-1b, IL-6, IL-12p70 and IL-23 measurements. *p#0.05, **p#0.01 and ***p#0.001, ****p#0.0001, mutants strains
vs CEA10 strain, isolates vs CEA10 strain.
doi:10.1371/journal.pone.0056651.g007
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Among the mutant strains tested, some of them resulted highly
virulent in vivo. Despite Af293 mutants were all UV-induced
colour mutants in the same genetic background, the albino Af293
VKWH1 strain and the brownish VKBR4 strain induced strong
morbidity and, in the case of Af293 VKBR4, high mortality in vivo.
As mentioned before, the surface layer on the dormant
Aspergillus conidia masks their recognition by the immune system
and hence prevents immune response. In particular, the hydro-
phobic rodlet and melanin layers immunologically silence airborne
moulds [37]. When we compared KO strains in the melanin
pathway and clinical Aspergillus isolates with supposedly analogous
spore colour morphologies, we observed a great variability in the
response. Our results suggest that, despite conferring obvious
virulence, melanin content could not solely account for the fungal
pathogenicity, since some Aspergillus isolates or the sandy-albino
Af293 VKWH2 and VKWH1 strains, induce a strong inflamma-
tory response either in vitro or in vivo whereas other colour mutants
do not. It is likely that rather than species-specific traits, several
strain-specific traits triggered and evolved under different
environmental conditions. This could, ultimately, confer different
potential pathogenic or immunostimulatory traits as suggested by
the different responses observed even between isolates from the
same clinical condition such as Af300, Af293 and CEA10.
We would like to suggest that pathogenic traits evolved as result
of rapid convergent evolution and adaptation to different
ecological niches present in the host. Recent work showed that
changes in carbon source altered the resistance of C. albicans to
antifungal drugs and osmotic and cell wall stresses, thus
influencing the virulence of C. albicans [42,43]. Fungal strains
could have evolved within the host the ability to escape immune
recognition. This theory could explain the gradient in the immune
responses observed as continuum in which passenger environ-
mental fungi enter the human body, become colonizers establish-
ing a commensal interaction and, upon failure of immune
surveillance, can become invaders, and potentially seriously harm
the host. We are actually testing this hyhotesis by enlarging the set
of strains and comparing them using genome wide association
studies. The greater resistance of A. fumigatus to environmental
stress and its ability to be inhaled may explain his prominent role
as a pathogen upon immune suppression.
We show the importance of addressing the immune reactivity of
different strains and evaluating differences among strains of the
same species in addition to the inter-individual variation. We also
show the importance in future studies to refer to pathogenic and
commensal strains rather than pathogenic and commensal species.
The wide strain-dependent variation of immunological signatures
suggest that the definition of markers of inflammation or
pathogenicity should be reassessed and based on the understand-
ing of strain specific armouries determining the success of host
invasion. The comparative genomics and genetic study of strains
carefully selected for their pro- or anti-inflammatory properties
will assist further investigation of the mechanism(s) by which
specific strains signal to the host and of the development of specific
targeted therapy.
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